Form 8-K - Current report:
SEC Accession No. 0001829126-24-004310
Filing Date
2024-06-18
Accepted
2024-06-18 17:02:05
Documents
16
Period of Report
2024-06-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nexalintech_8k.htm   iXBRL 8-K 40925
2 EX-99.1 nexalintech_ex99-1.htm EX-99.1 7579
3 GRAPHIC ex99-1_001.jpg GRAPHIC 8774
  Complete submission text file 0001829126-24-004310.txt   282412

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE nxl-20240613.xsd EX-101.SCH 3751
5 XBRL DEFINITION FILE nxl-20240613_def.xml EX-101.DEF 26615
6 XBRL LABEL FILE nxl-20240613_lab.xml EX-101.LAB 36725
7 XBRL PRESENTATION FILE nxl-20240613_pre.xml EX-101.PRE 25239
19 EXTRACTED XBRL INSTANCE DOCUMENT nexalintech_8k_htm.xml XML 5832
Mailing Address 1776 YORKTOWN SUITE 550 HOUSTON TX 77056
Business Address 1776 YORKTOWN SUITE 550 HOUSTON TX 77056 (832) 260-0222
Nexalin Technology, Inc. (Filer) CIK: 0001527352 (see all company filings)

EIN.: 275566468 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41507 | Film No.: 241052803
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)